Magnetic nanoparticles in MR imaging and drug delivery

Advanced Drug Delivery Reviews

Volumn 60, Issue 11, 2008, Pages 1252-1265

  Sun, Conroy ^a   Lee, Jerry S H ^b   Zhang, Miqin ^a  

^a University of Washington   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biodistribution; Cancer; Contrast agent; DNA; Drug delivery; Ligand; Magnetic nanoparticle; MRI; Peptide; siRNA; Targeting

Indexed keywords

CHEMOTHERAPY; CIVIL AVIATION; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; DRUG THERAPY; FOULING; HEALTH; IMAGING TECHNIQUES; MAGNETIC FIELDS; MAGNETIC MATERIALS; MAGNETIC MOMENTS; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; RESONANCE; SCALE (DEPOSITS); STABILIZERS (AGENTS); TECHNOLOGY;

(PL) PROPERTIES; BIO-MEDICAL APPLICATIONS; BIOLOGICAL INTERACTIONS; CARDIOVASCULAR DISEASE (CVD); CONTRAST AGENT (CA); ELSEVIER (CO); FUNCTIONAL LIGANDS; MAGNETIC (CE); MAGNETIC NANOPARTICLES (MNP'S); MAGNETIC RESONANCE IMAGING (MRI); MALIGNANT TUMORS; MOLECULAR LEVELS; MR IMAGING; NON-FOULING SURFACES; PERMEATION ENHANCERS;

MAGNETISM;

CHLOROTOXIN; CISPLATIN; CONTRAST MEDIUM; COPOLYMER; GELATINASE A; GEMCITABINE; IRON OXIDE; LIPOSOME; MAGNETITE; METAL NANOPARTICLE; MONOCLONAL ANTIBODY; NANOCRYSTAL; NANOPARTICLE; POLY(ETHYL 2 CYANOACRYLATE); POLYETHYLENEIMINE; POLYMER; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE; TRASTUZUMAB;

BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; CARDIOVASCULAR DISEASE; CELL CYCLE; CELLULAR DISTRIBUTION; COLLOID; CONTRAST ENHANCEMENT; DECOMPOSITION; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; HUMAN; MAGNETISM; MALIGNANT NEOPLASTIC DISEASE; MICELLE; MOLECULAR IMAGING; NANOMEDICINE; NANOTECHNOLOGY; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; NANOPARTICLES; TISSUE DISTRIBUTION;

EID: 46749142847     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.03.018     Document Type: Review

References (202)

1. Corot C., Robert P., Idee J.M., and Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced Drug Delivery Reviews 58 (2006) 1471-1504
2. Pankhurst Q.A., Connolly J., Jones S.K., and Dobson J. Applications of magnetic nanoparticles in biomedicine. Journal of Physics. D, Applied Physics 36 (2003) R167-R181
3. Dobson J. Magnetic nanoparticles for drug delivery. Drug Development Research 67 (2006) 55-60
4. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nature Reviews. Cancer 5 (2005) 161-171
5. Wickline S.A., Neubauer A.M., Winter P.M., Caruthers S.D., and Lanza G.M. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. Journal of Magnetic Resonance Imaging 25 (2007) 667-680
6. Corot C., Petry K.G., Trivedi R., Saleh A., Jonkmanns C., Le Bas J.F., Blezer E., Rausch M., Brochet B., Foster-Gareau P., Baleriaux D., Gaillard S., and Dousset V. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Investigative Radiology 39 (2004) 619-625
7. Tartaj P., Morales M.D., Veintemillas-Verdaguer S., Gonzalez-Carreno T., and Serna C.J. The preparation of magnetic nanoparticles for applications in biomedicine. Journal of Physics. D, Applied Physics 36 (2003) R182-R197
8. Gupta A.K., and Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26 (2005) 3995-4021
9. McNeil S.E. Nanotechnology for the biologist. Journal of Leukocyte Biology 78 (2005) 585-594
10. Frullano L., and Meade T.J. Multimodal MRI contrast agents. Journal of Biological Inorganic Chemistry 12 (2007) 939-949
11. Weissleder R., Bogdanov A., Neuwelt E.A., and Papisov M. Long-circulating iron oxides for MR imaging. Advanced Drug Delivery Reviews 16 (1995) 321-334
12. Wang Y.X., Hussain S.M., and Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. European Radiology 11 (2001) 2319-2331
13. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications - a review. Journal of Drug Targeting 6 (1998) 167-174
14. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., de la Rosette J., and Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New England Journal of Medicine 348 (2003) 2491-2499
15. Senyei A., Widder K., and Czerlinski G. Magnetic guidance of drug-carrying microspheres. Journal Of Applied Physics 49 (1978) 3578-3583
16. Neuberger T., Schopf B., Hofmann H., Hofmann M., and von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. Journal of Magnetism and Magnetic Materials 293 (2005) 483-496
17. Torchilin V.P. Multifunctional nanocarriers. Advanced Drug Delivery Reviews 58 (2006) 1532-1555
18. Zhang Y., Kohler N., and Zhang M.Q. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23 (2002) 1553-1561
19. Veiseh O., Sun C., Gunn J., Kohler N., Gabikian P., Lee D., Bhattarai N., Ellenbogen R., Sze R., Hallahan A., Olson J., and Zhang M.Q. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Letters 5 (2005) 1003-1008
20. Winau F., Westphal O., and Winau R. Paul Ehrlich - in search of the magic bullet. Microbes and Infection 6 (2004) 786-789
21. Lubbe A.S., Bergemann C., Riess H., Schriever F., Reichardt P., Possinger K., Matthias M., Dorken B., Herrmann F., Gurtler R., Hohenberger P., Haas N., Sohr R., Sander B., Lemke A.J., Ohlendorf D., Huhnt W., and Huhn D. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Research 56 (1996) 4686-4693
22. Lubbe A.S., Alexiou C., and Bergemann C. Clinical applications of magnetic drug targeting. Journal of Surgical Research 95 (2001) 200-206
23. Lubbe A.S., Bergemann C., Brock J., and McClure D.G. Physiological aspects in magnetic drug-targeting. Journal of Magnetism and Magnetic Materials 194 (1999) 149-155
24. Gallo J.M., and Hafeli U. Preclinical experiences with magnetic drug targeting: tolerance and efficacy and clinical experiences with magnetic drug targeting: a phase I study with 4¢-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Research 57 (1997) 3063-3064
25. Kohler N., Sun C., Wang J., and Zhang M.Q. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 21 (2005) 8858-8864
26. Kohler N., Sun C., Fichtenholtz A., Gunn J., Fang C., and Zhang M.Q. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2 (2006) 785-792
27. Chouly C., Pouliquen D., Lucet I., Jeune J.J., and Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. Journal of Microencapsulation 13 (1996) 245-255
28. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., Blunk T., and Muller R.H. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids and Surfaces. B, Biointerfaces 18 (2000) 301-313
29. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacological Reviews 53 (2001) 283-318
30. Suresh S. Biomechanics and biophysics of cancer cells. Acta Biomaterialia 3 (2007) 413-438
31. Puig-de-Morales-Marinkovic M., Turner K.T., Butler J.P., Fredberg J.J., and Suresh S. Viscoelasticity of the human red blood cell. American Journal of Physiology. Cell Physiology 293 (2007) C597-C605
32. Sahai E. Illuminating the metastatic process. Nature Reviews. Cancer 7 (2007) 737-749
33. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Natural Medicines 12 (2006) 895-904
34. Gupta G.P., and Massague J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
35. Mourino M.R. From Thales to Lauterbur, or from the lodestone to MR imaging: magnetism and medicine. Radiology 180 (1991) 593-612
36. Morrish A. The Physical Principles of Magnetism (2001), IEEE Press, New York
37. Lu A.H., Salabas E.L., and Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angewandte Chemie. International Edition 46 (2007) 1222-1244
38. Lin X.M., and Samia A.C.S. Synthesis, assembly and physical properties of magnetic nanoparticles. Journal of Magnetism and Magnetic Materials 305 (2006) 100-109
39. Weissleder R., Stark D.D., Engelstad B.L., Bacon B.R., Compton C.C., White D.L., Jacobs P., and Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR. American Journal of Roentgenology 152 (1989) 167-173
40. Willard M.A., Kurihara L.K., Carpenter E.E., Calvin S., and Harris V.G. Chemically prepared magnetic nanoparticles. International Materials Reviews 49 (2004) 125-170
41. Molday R.S., and Mackenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. Journal of Immunological Methods 52 (1982) 353-367
42. Shen T., Weissleder R., Papisov M., Bogdanov Jr. A., and Brady T.J. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magnetic Resonance in Medicine 29 (1993) 599-604
43. 4 (M = Fe, Co, Mn) nanoparticles. Journal of the American Chemical Society 126 (2004) 273-279
44. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., Kim S., Cho E.J., Yoon H.G., Suh J.S., and Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Natural Medicines 13 (2007) 95-99
45. Xu C.J., and Sun S.H. Monodisperse magnetic nanoparticles for biomedical applications. Polymer International 56 (2007) 821-826
46. Baldi G., Bonacchi D., Franchini M.C., Gentili D., Lorenzi G., Ricci A., and Ravagli C. Synthesis and coating of cobalt ferrite nanoparticles: a first step toward the obtainment of new magnetic nanocarriers. Langmuir 23 (2007) 4026-4028
47. Rana S., Gallo A., Srivastava R.S., and Misra R.D.K. On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics. Acta Biomaterialia 3 (2007) 233-242
48. Huber D.L. Synthesis, properties, and applications of iron nanoparticles. Small 1 (2005) 482-501
49. Peng S., Wang C., Xie J., and Sun S. Synthesis and stabilization of monodisperse Fe nanoparticles. Journal of the American Chemical Society 128 (2006) 10676-10677
50. Qiang Y., Antony J., Sharma A., Nutting J., Sikes D., and Meyer D. Iron/iron oxide core-shell nanoclusters for biomedical applications. Journal of Nanoparticle Research 8 (2006) 489-496
51. Sun S.H. Recent advances in chemical synthesis, self-assembly, and applications of FePt nanoparticles. Advanced Materials 18 (2006) 393-403
52. Hong R., Fischer N.O., Emrick T., and Rotello V.M. Surface PEGylation and ligand exchange chemistry of FePt nanoparticles for biological applications. Chemistry of Materials 17 (2005) 4617-4621
53. Sun S.H., Murray C.B., Weller D., Folks L., and Moser A. Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science 287 (2000) 1989-1992
54. Gao J., Liang G., Zhang B., Kuang Y., Zhang X., and Xu B. FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells. Journal of the American Chemical Society 129 (2007) 1428-1433
55. Gao J., Zhang B., Gao Y., Pan Y., Zhang X., and Xu B. Fluorescent magnetic nanocrystals by sequential addition of reagents in a one-pot reaction: a simple preparation for multifunctional nanostructures. Journal of the American Chemical Society 129 (2007) 11928-11935
56. Kim D.K., Kan D., Veres T., Normadin F., Liao J.K., Kim H.H., Lee S.H., Zahn M., and Muhammed M. Monodispersed Fe-Pt nanoparticles for biomedical applications. Journal Of Applied Physics 97 (2005)
57. de la Presa P., Multigner M., Morales M.P., Rueda T., Fernandez-Pinel E., and Hernando A. Synthesis and characterization of FePt/Au core-shell nanoparticles. Journal of Magnetism and Magnetic Materials 316 (2007) E753-E755
58. Reiss G., and Hutten A. Magnetic nanoparticles - applications beyond data storage. Nature Materials 4 (2005) 725-726
59. Bai J.M., and Wang J.P. High-magnetic-moment core-shell-type FeCo-Au/Ag nanoparticles. Applied Physics Letters 87 (2005)
60. Seo W.S., Lee J.H., Sun X., Suzuki Y., Mann D., Liu Z., Terashima M., Yang P.C., McConnell M.V., Nishimura D.G., and Dai H. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nature Matters 5 (2006) 971-976
61. Berry C.C., and Curtis A.S.G. Functionalisation of magnetic nanoparticles for applications in biomedicine. Journal of Physics. D, Applied Physics 36 (2003) R198-R206
62. Portet D., Denizot B., Rump E., Lejeune J.J., and Jallet P. Nonpolymeric coatings of iron oxide colloids for biological use as magnetic resonance imaging contrast agents. Journal of Colloid and Interface Science 238 (2001) 37-42
63. Fauconnier N., Pons J.N., Roger J., and Bee A. Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. Journal of Colloid and Interface Science 194 (1997) 427-433
64. Zhang C., Wangler B., Morgenstern B., Zentgraf H., Eisenhut M., Untenecker H., Kruger R., Huss R., Seliger C., Semmler W., and Kiessling F. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Langmuir 23 (2007) 1427-1434
65. Mornet S., Vasseur S., Grasset F., Veverka P., Goglio G., Demourgues A., Portier J., Pollert E., and Duguet E. Magnetic nanoparticle design for medical applications. Progress in Solid State Chemistry 34 (2006) 237-247
66. Sato T. Stabilization of Colloidal Dispersions by Polymer Adsoption (1980), Dekker, New York
67. Gupta A.K., Naregalkar R.R., Vaidya V.D., and Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2 (2007) 23-39
68. Josephson L., Tung C.H., Moore A., and Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjugate Chemistry 10 (1999) 186-191
69. Wunderbaldinger P., Josephson L., and Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjugate Chemistry 13 (2002) 264-268
70. Schellenberger E.A., Bogdanov Jr. A., Hogemann D., Tait J., Weissleder R., and Josephson L. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Molecular Imaging 1 (2002) 102-107
71. Zhang M., and Ferrari M. Hemocompatible polyethylene glycol films on silicon. Journal of Biomedical Microdevices 1 (1998) 81-89
72. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
73. Butterworth M.D., Illum L., and Davis S.S. Preparation of ultrafine silica- and PEG-coated magnetite particles. Colloids and Surfaces. A, Physicochemical and Engineering Aspects 179 (2001) 93-102
74. Flesch C., Unterfinger Y., Bourgeat-Lami E., Duguet E., Delaite C., and Dumas P. Poly(ethylene glycol) surface coated magnetic particles. Macromolecular Rapid Communications 26 (2005) 1494-1498
75. Lu Y., Yin Y.D., Mayers B.T., and Xia Y.N. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Letters 2 (2002) 183-186
76. Zhang Y., Sun C., Kohler N., and Zhang M.Q. Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomedical Microdevices 6 (2004) 33-40
77. Kohler N., Fryxell G.E., and Zhang M.Q. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. Journal of the American Chemical Society 126 (2004) 7206-7211
78. Lee H., Lee E., Kim D.K., Jang N.K., Jeong Y.Y., and Jon S. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. Journal of the American Chemical Society 128 (2006) 7383-7389
79. Yuan J.J., Armes S.P., Takabayashi Y., Prassides K., Leite C.A.P., Galembeck F., and Lewis A.L. Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles. Langmuir 22 (2006) 10989-10993
80. Lutz J.F., Stiller S., Hoth A., Kaufner L., Pison U., and Cartier R. One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules 7 (2006) 3132-3138
81. Hu F.Q., Wei L., Zhou Z., Ran Y.L., Li Z., and Gao M.Y. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Advanced Materials 18 (2006) 2553-+
82. Wang L.Y., Bao J., Wang L., Zhang F., and Li Y.D. One-pot synthesis and bioapplication of amine-functionalized magnetite nanoparticles and hollow nanospheres. Chemistry. A, European Journal 12 (2006) 6341-6347
83. 4 particles by precipitation in the presence of PVA at high pH. Journal of Colloid and Interface Science 177 (1996) 490-494
84. Mikhaylova M., Jo Y.S., Kim D.K., Bobrysheva N., Andersson Y., Eriksson T., Osmolowsky M., Semenov V., and Muhammed M. The effect of biocompatible coating layers on magnetic properties of superparamagnetic iron oxide nanoparticles. Hyperfine Interactions 156 (2004) 257-263
85. Mikhaylova M., Kim D.K., Bobrysheva N., Osmolowsky M., Semenov V., Tsakalakos T., and Muhammed M. Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 20 (2004) 2472-2477
86. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews. Drug Discovery 4 (2005) 145-160
87. Nasongkla N., Bey E., Ren J.M., Ai H., Khemtong C., Guthi J.S., Chin S.F., Sherry A.D., Boothman D.A., and Gao J.M. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Letters 6 (2006) 2427-2430
88. Lecommandoux S., Sandre O., Checot F., and Perzynski R. Smart hybrid magnetic self-assembled micelles and hollow capsules. Progress in Solid State Chemistry 34 (2006) 171-179
89. Martina M.S., Fortin J.P., Menager C., Clement O., Barratt G., Grabielle-Madelmont C., Gazeau F., Cabuil V., and Lesieur S. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. Journal of the American Chemical Society 127 (2005) 10676-10685
90. Stober W., Fink A., and Bohn E. Controlled growth of monodisperse silica spheres in micron size range. Journal of Colloid and Interface Science 26 (1968) 62-69
91. Tada D.B., Vono L.L.R., Duarte E.L., Itri R., Kiyohara P.K., Baptista M.S., and Rossi L.M. Methylene blue-containing silica-coated magnetic particles: a potential magnetic carrier for photodynamic therapy. Langmuir 23 (2007) 8194-8199
92. Tan W.H., Wang K.M., He X.X., Zhao X.J., Drake T., Wang L., and Bagwe R.P. Bionanotechnology based on silica nanoparticles. Medicinal Research Reviews 24 (2004) 621-638
93. Ma D.L., Guan J.W., Normandin F., Denommee S., Enright G., Veres T., and Simard B. Multifunctional nano-architecture for biomedical applications. Chemistry of Materials 18 (2006) 1920-1927
94. Prime K.L., and Whitesides G.M. Self-assembled organic monolayers - model systems for studying adsorption of proteins at surfaces. Science 252 (1991) 1164-1167
95. Bain C.D., Troughton E.B., Tao Y.T., Evall J., Whitesides G.M., and Nuzzo R.G. Formation of monolayer films by the spontaneous assembly of organic thiols from solution onto gold. Journal Of The American Chemical Society 111 (1989) 321-335
96. Choi J.S., Jun Y.W., Yeon S.I., Kim H.C., Shin J.S., and Cheon J. Biocompatible heterostructured nanoparticles for multimodal biological detection. Journal of the American Chemical Society 128 (2006) 15982-15983
97. Aslam M., and Dent A. Bioconjugation (1998), Macmillan Reference Ltd, London, UK
98. Hermanson G. Bioconjugate techniques (1996), Academic Press, San Diego
99. Sun E.Y., Josephson L., and Weissleder R. "Clickable" nanoparticles for targeted imaging. Molecular Imaging 5 (2006) 122-128
100. Nandivada H., Jiang X.W., and Lahann J. Click chemistry: versatility and control in the hands of materials scientists. Advanced Materials 19 (2007) 2197-2208
101. Myers D. Surfaces, Interfaces, and Colloids: Principles and Applications (1991), VCH Publishers, New York
102. Bertorelle F., Wilhelm C., Roger J., Gazeau F., Menager C., and Cabuil V. Fluorescence-modified superparamagnetic nanoparticles: intracellular uptake and use in cellular imaging. Langmuir 22 (2006) 5385-5391
103. Lee J.H., Jun Y.W., Yeon S.I., Shin J.S., and Cheon J. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angewandte Chemie. International Edition 45 (2006) 8160-8162
104. Weissleder R., and Ntziachristos V. Shedding light onto live molecular targets. Natural Medicines 9 (2003) 123-128
105. Josephson L., Kircher M.F., Mahmood U., Tang Y., and Weissleder R. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjugate Chemistry 13 (2002) 554-560
106. Kircher M.F., Mahmood U., King R.S., Weissleder R., and Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Research 63 (2003) 8122-8125
107. Trehin R., Figueiredo J.L., Pittet M.J., Weissleder R., Josephson L., and Mahmood U. Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia 8 (2006) 302-311
108. Chen L.T., and Weiss L. The role of the sinus wall in the passage of erythrocytes through the spleen. Blood 41 (1973) 529-537
109. Soo Choi H., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., Bawendi M.G., and Frangioni J.V. Renal clearance of quantum dots. Nature Biotechnology 25 (2007) 1165-1170
110. Decuzzi P., and Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27 (2006) 5307-5314
111. Storm G., Belliot S.O., Daemen T., and Lasic D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Advanced Drug Delivery Reviews 17 (1995) 31-48
112. Fujita T., Nishikawa M., Ohtsubo Y., Ohno J., Takakura Y., Sezaki H., and Hashida M. Control of in vivo fate of albumin derivatives utilizing combined chemical modification. Journal of Drug Targeting 2 (1994) 157-165
113. Papisov M.I., Bogdanov A., Schaffer B., Nossiff N., Shen T., Weissleder R., and Brady T.J. Colloidal magnetic-resonance contrast agents - effect of particle surface on biodistribution. Journal of Magnetism and Magnetic Materials 122 (1993) 383-386
114. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of Controlled Release 65 (2000) 271-284
115. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advances in Enzyme Regulation 41 (2001) 189-207
116. Clement O., Siauve N., Lewin M., de Kerviler E., Cuenod C.A., and Frija G. Contrast agents in magnetic resonance imaging of the liver: present and future. Biomedicine and Pharmacotherapy 52 (1998) 51-58
117. Stark D.D., Weissleder R., Elizondo G., Hahn P.F., Saini S., Todd L.E., Wittenberg J., and Ferrucci J.T. Superparamagnetic iron-oxide - clinical-application as a contrast agent for MR imaging of the liver. Radiology 168 (1988) 297-301
118. Weissleder R., Bogdanov A., and Papisov M. Drug targeting in magnetic resonance imaging. Magnetic Resonance Quarterly 8 (1992) 55-63
119. Kresse M., Wagner S., Pfefferer D., Lawaczeck R., Elste V., and Semmler W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magnetic Resonance in Medicine 40 (1998) 236-242
120. Kresse M., Wagner S., Pfefferer D., Lawaczeck R., Elste V., and Semmler W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magnetic Resonance in Medicine 40 (1998) 236-242
121. Farokhzad O.C., Jon S., Khademhosseini A., Tran T.N., Lavan D.A., and Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Research 64 (2004) 7668-7672
122. Herr J.K., Smith J.E., Medley C.D., Shangguan D., and Tan W. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Analytical Chemistry 78 (2006) 2918-2924
123. Yigit M.V., Mazumdar D., Kim H.K., Lee J.H., Odintsov B., and Lu Y. Smart "turn-on" magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles. ChemBioChem 8 (2007) 1675-1678
124. Weissleder R., Kelly K., Sun E.Y., Shtatland T., and Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nature Biotechnology 23 (2005) 1418-1423
125. Cerdan S., Lotscher H.R., Kunnecke B., and Seelig J. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magnetic Resonance in Medicine 12 (1989) 151-163
126. Bulte J.W., Hoekstra Y., Kamman R.L., Magin R.L., Webb A.G., Briggs R.W., Go K.G., Hulstaert C.E., Miltenyi S., The T.H., et al. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magnetic Resonance in Medicine 25 (1992) 148-157
127. Weissleder R., Lee A.S., Fischman A.J., Reimer P., Shen T., Wilkinson R., Callahan R.J., and Brady T.J. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology 181 (1991) 245-249
128. Tiefenauer L.X., Kuhne G., and Andres R.Y. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjugate Chemistry 4 (1993) 347-352
129. Artemov D., Mori N., Ravi R., and Bhujwalla Z.M. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Research 63 (2003) 2723-2727
130. Artemov D., Mori N., Okollie B., and Bhujwalla Z.M. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magnetic Resonance in Medicine 49 (2003) 403-408
131. Huh Y.M., Jun Y.W., Song H.T., Kim S., Choi J.S., Lee J.H., Yoon S., Kim K.S., Shin J.S., Suh J.S., and Cheon J. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. Journal of the American Chemical Society 127 (2005) 12387-12391
132. Foon K.A. Biological response modifiers - the new immunotherapy. Cancer Research 49 (1989) 1621-1639
133. Jain R.K. Transport of molecules in the tumor interstitium - a review. Cancer Research 47 (1987) 3039-3051
134. Folkman J. Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 285 (1971) 1182-1186
135. Ruoslahti E. Specialization of tumour vasculature. Nature Reviews. Cancer 2 (2002) 83-90
136. Neri D., and Bicknell R. Tumour vascular targeting. Nature Reviews. Cancer 5 (2005) 436-446
137. Montet X., Montet-Abou K., Reynolds F., Weissleder R., and Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia 8 (2006) 214-222
138. Sunderland C.J., Steiert M., Talmadge J.E., Derfus A.M., and Barry S.E. Targeted nanoparticles for detecting and treating cancer. Drug Development Research 67 (2006) 70-93
139. Zhang C.F., Jugold M., Woenne E.C., Lammers T., Morgenstern B., Mueller M.M., Zentgraf H., Bock M., Eisenhut M., Semmler W., and Kiessling F. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Research 67 (2007) 1555-1562
140. Reddy G.R., Bhojani M.S., McConville P., Moody J., Moffat B.A., Hall D.E., Kim G., Koo Y.E.L., Woolliscroft M.J., Sugai J.V., Johnson T.D., Philbert M.A., Kopelman R., Rehemtulla A., and Ross B.D. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clinical Cancer Research 12 (2006) 6677-6686
141. Veiseh M., Gabikian P., Bahrami S.B., Veiseh O., Zhang M., Hackman R.C., Ravanpay A.C., Stroud M.R., Kusuma Y., Hansen S.J., Kwok D., Munoz N.M., Sze R.W., Grady W.M., Greenberg N.M., Ellenbogen R.G., and Olson J.M. Tumor paint: a chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Research 67 (2007) 6882-6888
142. Lyons S.A., O'Neal J., and Sontheimer H. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 39 (2002) 162-173
143. Kachra Z., Beaulieu E., Delbecchi L., Mousseau N., Berthelet F., Moumdjian R., Del Maestro R., and Beliveau R. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clinical and Experimental Metastasis 17 (1999) 555-566
144. Deshane J., Garner C.C., and Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. Journal of Biological Chemistry 278 (2003) 4135-4144
145. Quintana A., Raczka E., Piehler L., Lee I., Myc A., Majoros I., Patri A.K., Thomas T., Mule J., and Baker J.R. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharmaceutical Research 19 (2002) 1310-1316
146. Weitman S.D., Lark R.H., Coney L.R., Fort D.W., Frasca V., Zurawski Jr. V.R., and Kamen B.A. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Research 52 (1992) 3396-3401
147. Ross J.F., Chaudhuri P.K., and Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73 (1994) 2432-2443
148. Sun C., Sze R., and Zhang M.Q. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. Journal of Biomedical Materials Research Part A 78A (2006) 550-557
149. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
150. Mrsny R. Active targeting strategies in cancer with a focus on potential nanotechnology applications. In: Amiji M.M. (Ed). Nanotechnology for Cancer Therapy (2007), CRC Press, Boca Raton, FL
151. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., and Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnology 18 (2000) 410-414
152. Wadia J.S., and Dowdy S.F. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Advanced Drug Delivery Reviews 57 (2005) 579-596
153. Koch A.M., Reynolds F., Kircher M.F., Merkle H.P., Weissleder R., and Josephson L. Uptake and metabolism of a dual fluorochrome tat-nanoparticle in HeLa cells. Bioconjugate Chemistry 14 (2003) 1115-1121
154. Bareford L.M., and Swaan P.W. Endocytic mechanisms for targeted drug delivery. Advanced Drug Delivery Reviews 59 (2007) 748-758
155. Tung C.H., Mahmood U., Bredow S., and Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Research 60 (2000) 4953-4958
156. Weissleder R., Tung C.H., Mahmood U., and Bogdanov Jr. A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnology 17 (1999) 375-378
157. Boussif O., Lezoualch F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo - polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 7297-7301
158. Garnett M.C., and Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occupational Medicine (Oxford) 56 (2006) 307-311
159. Patri A.K., Dobrovolskaia M.A., Stern S.T., and McNeil S.E. Preclinical characterization of engineered nanoparticles intended for cancer therapeutics. In: Amiji M.M. (Ed). Nanotechnology for Cancer Therapy (2007), CRC Press, Boca Raton, FL
160. Mitchell D., and Cohen M. MRI Principles (2004), Saunders, Philadelphia, PA
161. Brown M., and Semelka R. MRI: Basic Principles and Applications (2003), Wiley-Liss, Hoboken, NJ
162. Josephson L., Lewis J., Jacobs P., Hahn P.F., and Stark D.D. The effects of iron-oxides on proton relaxivity. Magnetic Resonance Imaging 6 (1988) 647-653
163. Jun Y.W., Huh Y.M., Choi J.S., Lee J.H., Song H.T., Kim S., Yoon S., Kim K.S., Shin J.S., Suh J.S., and Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. Journal of the American Chemical Society 127 (2005) 5732-5733
164. Semelka R.C., and Helmberger T.K. Contrast agents for MR imaging of the liver. Radiology 218 (2001) 27-38
165. Harisinghani M.G., and Weissleder R. Sensitive, noninvasive detection of lymph node metastases. PLoS Medicine 1 (2004) e66
166. Enochs W.S., Harsh G., Hochberg F., and Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. Journal of Magnetic Resonance Imaging 9 (1999) 228-232
167. Neuwelt E.A., Varallyay P., Bago A.G., Muldoon L.L., Nesbit G., and Nixon R. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathology and Applied Neurobiology 30 (2004) 456-471
168. Varallyay P., Nesbit G., Muldoon L.L., Nixon R.R., Delashaw J., Cohen J.I., Petrillo A., Rink D., and Neuwelt E.A. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR. American Journal of Neuroradiology 23 (2002) 510-519
169. Taschner C.A., Wetzel S.G., Tolnay M., Froehlich J., Merlo A., and Radue E.W. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR. American Journal of Roentgenology 185 (2005) 1477-1486
170. Koo Y.E., Reddy G.R., Bhojani M., Schneider R., Philbert M.A., Rehemtulla A., Ross B.D., and Kopelman R. Brain cancer diagnosis and therapy with nanoplatforms. Advanced Drug Delivery Reviews 58 (2006) 1556-1577
171. Sun C., Veiseh O., Gunn J., Fang C., Hansen S., Lee D., Sze R., Ellenbogen R.G., Olson J., and Zhang M. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 4 (2008) 372-379
172. Sosnovik D.E., Nahrendorf M., and Weissleder R. Molecular magnetic resonance imaging in cardiovascular medicine. Circulation 115 (2007) 2076-2086
173. Wickline S.A., Neubauer A.M., Winter P.M., Caruthers S.D., and Lanza G.M. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. Journal of Magnetic Resonance Imaging 25 (2007) 667-680
174. Kooi M.E., Cappendijk V.C., Cleutjens K., Kessels A.G.H., Kitslaar P., Borgers M., Frederik P.M., Daemen M., and van Engelshoven J.M.A. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107 (2003) 2453-2458
175. Trivedi R.A., U-King-Im J.M., Graves M.J., Cross J.J., Horsley J., Goddard M.J., Skepper J.N., Quartey G., Warburton E., Joubert I., Wang L.Q., Kirkpatrick P.J., Brown J., and Gillard J.H. In vivo detection of macrophages in human carotid atheroma - temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35 (2004) 1631-1635
176. Kelly K.A., Nahrendorf M., Yu A.M., Reynolds F., and Weissleder R. In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Molecular Imaging and Biology 8 (2006) 201-207
177. Nahrendorf M., Jaffer F.A., Kelly K.A., Sosnovik D.E., Aikawa E., Libby P., and Weissleder R. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114 (2006) 1504-1511
178. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 (2001) 316-333
179. Weissleder R. Molecular imaging in cancer. Science 312 (2006) 1168-1171
180. Bulte J.W., and Kraitchman D.L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR in Biomedicine 17 (2004) 484-499
181. Schellenberger E.A., Sosnovik D., Weissleder R., and Josephson L. Magneto/optical annexin V, a multimodal protein. Bioconjugate Chemistry 15 (2004) 1062-1067
182. Sosnovik D.E., and Weissleder R. Emerging concepts in molecular MRI. Current Opinion in Biotechnology 18 (2007) 4-10
183. Grief A.D., and Richardson G. Mathematical modelling of magnetically targeted drug delivery. Journal of Magnetism and Magnetic Materials 293 (2005) 455-463
184. Alexiou C., Arnold W., Klein R.J., Parak F.G., Hulin P., Bergemann C., Erhardt W., Wagenpfeil S., and Lubbe A.S. Locoregional cancer treatment with magnetic drug targeting. Cancer Research 60 (2000) 6641-6648
185. Alexiou C., Schmid R.J., Jurgons R., Kremer M., Wanner G., Bergemann C., Huenges E., Nawroth T., Arnold W., and Parak F.G. Targeting cancer cells: magnetic nanoparticles as drug carriers. European Biophysics Journal 35 (2006) 446-450
186. Mornet S., Vasseur S., Grasset F., and Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. Journal of Materials Chemistry 14 (2004) 2161-2175
187. Schulze K., Koch A., Schopf B., Petri A., Steitz B., Chastellain M., Hofmann M., Hofmann H., and von Rechenberg B. Intraarticular application of superparamagnetic nanoparticles and their uptake by synovial membrane - an experimental study in sheep. Journal of Magnetism and Magnetic Materials 293 (2005) 419-432
188. Jain T.K., Morales M.A., Sahoo S.K., Leslie-Pelecky D.L., and Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Molecular Pharmacology 2 (2005) 194-205
189. Yang J., Lee H., Hyung W., Park S.B., and Haam S. Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics. Journal of Microencapsulation 23 (2006) 203-212
190. Kute T., Lack C.M., Willingham M., Bishwokama B., Williams H., Barrett K., Mitchell T., and Vaughn J.P. Development of Herceptin resistance in breast cancer cells. Cytometry A 57 (2004) 86-93
191. Ito A., Kuga Y., Honda H., Kikkawa H., Horiuchi A., Watanabe Y., and Kobayashi T. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Letter 212 (2004) 167-175
192. McFerrin M.B., and Sontheimer H. A role for ion channels in glioma cell invasion. Neuron Glia Biology 2 (2006) 39-49
193. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Advanced Drug Delivery Reviews 54 (2002) 631-651
194. Juliano R.L., Alahari S., Yoo H., Kole R., and Cho M. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharmaceutical Research 16 (1999) 494-502
195. Scherer F., Anton M., Schillinger U., Henke J., Bergemann C., Kruger A., Gansbacher B., and Plank C. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 9 (2002) 102-109
196. Krotz F., de Wit C., Sohn H.Y., Zahler S., Gloe T., Pohl U., and Plank C. Magnetofection - a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Molecular Therapy 7 (2003) 700-710
197. Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Therapy 13 (2006) 283-287
198. Pan B.F., Cui D.X., Sheng Y., Ozkan C.G., Gao F., He R., Li Q., Xu P., and Huang T. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Research 67 (2007) 8156-8163
199. Schillinger U., Brill T., Rudolph C., Huth S., Gersting S., Krotz F., Hirschberger J., Bergemann C., and Plank C. Advances in magnetofection - magnetically guided nucleic acid delivery. Journal of Magnetism and Magnetic Materials 293 (2005) 501-508
200. Ryther R.C.C., Flynt A.S., Phillips J.A., and Patton J.G. siRNA therapeutics: big potential from small RNAs. Gene Therapy 12 (2005) 5-11
201. Mykhaylyk O., Vlaskou D., Tresilwised N., Pithayanukul P., Moller W., and Plank C. Magnetic nanoparticle formulations for DNA and siRNA delivery. Journal of Magnetism and Magnetic Materials 311 (2007) 275-281
202. Medarova Z., Pham W., Farrar C., Petkova V., and Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Natural Medicines 13 (2007) 372-377